View More
Review slides with commentary in slidenotes from pharmacist and nursing experts on patient counseling, monitoring, and managing adverse events associated with avelumab, enfortumab vedotin, and erdafitinib in urothelial carcinoma.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.